BASTA, GIUSEPPINA
 Distribuzione geografica
Continente #
AS - Asia 3.093
NA - Nord America 1.280
EU - Europa 636
SA - Sud America 498
AF - Africa 47
OC - Oceania 8
Totale 5.562
Nazione #
SG - Singapore 1.337
US - Stati Uniti d'America 1.213
CN - Cina 666
BR - Brasile 407
VN - Vietnam 338
HK - Hong Kong 327
IT - Italia 185
FR - Francia 182
KR - Corea 109
JP - Giappone 102
NL - Olanda 55
IN - India 43
DE - Germania 42
GB - Regno Unito 35
FI - Finlandia 33
AR - Argentina 29
BD - Bangladesh 27
CA - Canada 26
IQ - Iraq 22
MX - Messico 20
EC - Ecuador 16
IL - Israele 16
ID - Indonesia 14
TR - Turchia 13
RU - Federazione Russa 12
AT - Austria 11
CO - Colombia 11
PE - Perù 11
PH - Filippine 11
PL - Polonia 11
ZA - Sudafrica 11
SA - Arabia Saudita 10
PT - Portogallo 9
TH - Thailandia 8
ES - Italia 7
IE - Irlanda 7
KE - Kenya 7
MA - Marocco 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
PY - Paraguay 6
AU - Australia 5
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
GR - Grecia 5
PK - Pakistan 5
UA - Ucraina 5
UZ - Uzbekistan 5
VE - Venezuela 5
ET - Etiopia 4
LB - Libano 4
LK - Sri Lanka 4
NP - Nepal 4
BH - Bahrain 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
JO - Giordania 3
KZ - Kazakistan 3
MD - Moldavia 3
MY - Malesia 3
NO - Norvegia 3
SE - Svezia 3
AL - Albania 2
BE - Belgio 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
CH - Svizzera 2
DM - Dominica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
LT - Lituania 2
LV - Lettonia 2
ML - Mali 2
PA - Panama 2
RO - Romania 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CM - Camerun 1
DK - Danimarca 1
GA - Gabon 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
MT - Malta 1
MZ - Mozambico 1
NI - Nicaragua 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SL - Sierra Leone 1
Totale 5.558
Città #
Singapore 810
Hong Kong 320
Santa Clara 315
Hefei 245
San Jose 212
Lauterbourg 153
Beijing 143
Ashburn 119
Ho Chi Minh City 111
Seoul 104
Los Angeles 98
Tokyo 84
Hanoi 76
Cascina 52
São Paulo 41
Buffalo 29
Dallas 29
New York 26
Da Nang 25
Helsinki 25
Haiphong 20
Rio de Janeiro 18
Orem 15
Belo Horizonte 13
Pisa 13
Frankfurt am Main 12
Minamishinagawa 12
Naples 12
Rome 12
Milan 11
Council Bluffs 10
Düsseldorf 10
Florence 10
Baghdad 9
Bengaluru 9
Brooklyn 9
Chennai 9
Atlanta 8
Chicago 8
Guangzhou 8
Juiz de Fora 8
Lappeenranta 8
Lima 8
Warsaw 8
Campinas 7
Denver 7
Falkenstein 7
Guayaquil 7
Johannesburg 7
Montreal 7
Thái Bình 7
Thái Nguyên 7
Erbil 6
Nairobi 6
Nuremberg 6
Phoenix 6
Quảng Ngãi 6
Salvador 6
Biên Hòa 5
Boston 5
Curitiba 5
Dhaka 5
Dublin 5
Elk Grove Village 5
Jeddah 5
London 5
Montevideo 5
Porto Alegre 5
Shanghai 5
Vienna 5
Baku 4
Brasília 4
Can Tho 4
Colombo 4
Ha Long 4
Hải Dương 4
Mexico City 4
Nova Iguaçu 4
Osaka 4
Port of Spain 4
Quito 4
Ribeirão Preto 4
Tashkent 4
Addis Ababa 3
Altamura 3
Amman 3
Aracaju 3
Asunción 3
Athens 3
Birmingham 3
Blumenau 3
Bristol 3
Buenos Aires 3
Bắc Giang 3
Cabo Frio 3
Calgary 3
Cape Town 3
Casablanca 3
Ercolano 3
Formosa 3
Totale 3.532
Nome #
The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity? 90
Variations of circulating miRNA in paediatric patients with Heart Failure supported with Ventricular Assist Device: a pilot study 87
Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study 79
S 18886 Inhibits Thromboxane A2 Receptor-dependent Tissue Factor Expression, Procoagulant Activity And NADP(H) Oxidase Activation In Stimulated Endothelial Cells 77
Prodotti di glicosilazione avanzata: possibili implicazioni per l'aterosclerosi nel diabete 75
A possible role for ST2 as prognostic biomarker for COVID-19 73
Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies 72
Monitoring osseointegration and degradation of Mg-alloy implants through plasma biomarkers of inflammation and bone regeneration 72
Interaction of Uric Acid and Neutrophil-to-Lymphocyte Ratio for Cardiometabolic Risk Stratification and Prognosis in Coronary Artery Disease Patients 68
Liver Transplantation Is Associated with an Unfavourable Metabolic Signature 66
An extensive evaluation of hepatic markers of damage and regeneration in controlled and uncontrolled donation after circulatory death. 66
Extended criteria grafts and emerging therapeutics strategy in liver transplantation. The unstable balance between damage and repair 66
Parallel decrease of tissue factor surface exposure and increase of tissue factor microparticle release by the n-3 fatty acid docosahexaenoate in endothelial cells 63
Epigenetic Regulation of Cardiac Troponin Genes in Pediatric Patients with Heart Failure Supported by Ventricular Assist Device 62
Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality 59
EARLY INCREASE IN N(EPSILON)-CARBOXY-METHYL-LYSINE AND DECREASE IN sRAGE PLASMA VALUES IN DE NOVO LIVER TRANSPLANTATION 58
Differential ability of human endothelial cells to internalize and express exogenous DNA 58
Sequential Normothermic Regional Perfusion and End-ischemic Ex Situ Machine Perfusion Allow the Safe Use of Very Old DCD Donors in Liver Transplantation 58
The Positive Impact of Early Frailty Levels on Mortality in Elderly Patients with Severe Aortic Stenosis Undergoing Transcatheter/Surgical Aortic Valve Replacement. 58
Langmuir-Blodgett films of antibodies as mediators of endothelial cell adhesion on polyurethanes 56
New inflammatory and oxidative stress-based biomarker changes in response to a half-marathon in recreational athletes 54
Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients 54
Polyunsaturated omega-3 fatty acids reduce the plasma levels of N-epsilon-(carbpximethyl) lysine adducts of proteins in patients with myocardial infarction 50
PCSK9 and atherosclerosis: Looking beyond LDL regulation 50
miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles 49
Direct or indirect endothelial damage? An unresolved question 49
Normothermic regional perfusion in liver transplantation from donation after cardiocirculatory death: Technical, biochemical, and regulatory aspects and review of literature 49
Minimally modified, but not fully oxidized LDL, induce VCAM-1 expression in vascular endothelium 48
A New Natural Antioxidant Mixture Protects against Oxidative and DNA Damage in Endothelial Cell Exposed to Low-Dose Irradiation 48
Lack of effect of alpha-tocopherol on in vitro angiogenesis 47
Small-scale laser based electron accelerators for biology and medicine: a comparative study of the biological effectiveness 47
COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? 46
Advanced glycation end products, leukocyte telomere length, and mitochondrial DNA copy number in patients with coronary artery disease and alterations of glucose homeostasis: From the GENOCOR study 45
The role of sequential normothermic regional perfusion and end-ischemic normothermic machine perfusion in liver transplantation from very extended uncontrolled donation after cardiocirculatory death 45
At least 2 distinct patways generating reactive oxygen species mediante vascular cell adhesion molecule induced by advanced glycation end products 44
Effects of sex steroid hormones on vascular cell adhesion molecule-1 gene expression in activated endothelial cells 43
Thrombolysis accelerated by ultrasound and microbubbles 43
Effects of antioxidant nutrients on ionizing radiation-induced oxidative stress 43
Procoagulant activity of circulating microparticles is associated with the presence of moderate calcified plaque burden detected by multislice computed tomography 42
Plasma levels of n epsilon-(carboxymethyl) lysine increase after angioplasty and stent positioning in coronary artery desease patients 42
Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjects 41
Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study 41
Extracellular Vesicles and Intercellular Communication: Challenges for In Vivo Molecular Imaging and Tracking 40
Cytocompatibility evaluation of gum Arabic-coated ultra-pure boron nitride nanotubes on human cells 39
Aspetti patogenetici comuni tra stenosi aortica calcifica e aterosclerosi: ruolo del recettore dei prodotti di glicosilazione avanzata 39
The effect of Ginkgo biloba in isolated ischemic/reperfused rat heart. A link between vitamin E preservation and prostaglandin biosynthesis 39
Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure 39
Circulating levels of lectin-like oxidized low-density lipoprotein receptor-1 are associated with inflammatory markers 38
Inverse Association between Circulating Levels of Soluble Receptor for Advanced Glycation End-Products and Coronary Plaque Burden 37
Effects of single and fractionated low-dose irradiation on vascular endothelial cells 36
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 36
THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (RAGE) AXIS IN LIVER TRANSPLANTATION 35
Glucose metabolism in high-risk subjects for type 2 diabetes carrying the rs7903146 TCF7L2 gene variant 35
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses 34
Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction 34
Therapeutic effect of diagnostic ultrasound on enzymatic thrombolysis. An in vitro study on blood of normal subjects and patients with coronary disease 34
EVALUATION OF METABOLIC PARAMETERS OF HEPATIC DYSFUNCTION IN SUBJECTS WITH HEPATOCELLULAR CARCINOMA AND THEIR CHANGE AFTER LIVER TRANSPLANTATION: A METABOLOMIC APPROACH 34
The prognostic impact of objective nutritional indices in elderly patients with ST-elevation myocardial infarction undergoing PCI 33
Increased lipotoxicity and insulin resistance in non diabetic patients with hepatocellular carcinoma 32
n-3 expression polyunsaturated fatty acids inhibit COX-2 expression 32
Advanced glycation endproducts and the accelerated atherosclerosis in diabetes 32
Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma. 32
Cytocompatibility evaluation of glycol-chitosan coated boron nitride nanotubes in human endothelial cells 32
Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality 31
Soluble RAGE plasma levels are inversely associated to severity of coronary atherosclerosis and are genetically influenced 31
Pericardial fat but not calcium score correlates with oxidative products in patients with known coronary artery disease 31
Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis 31
NAD(P)H oxidase-mediated generation of reactive oxygen species is implicated in the endothelial induction of VCAM-1 and ICAM-1, but not E-selectin, by advanced glycation endproducts 30
Plasma N-epsilon-(carboxymethyl)lysine levels are associated with the extent of vessel injury after coronary arterial stenting 30
Decreased plasma levels of RAGE are associated to coronary fibro-lipidic wall volume in patients with proven or suspected CAD 30
Meccanismi molecolari d'azione dei fattori di rischio cardiovascolare 29
Early degrees of LDL oxidation induce VCAM-1 expression in cultured endothelial cells 29
Can Dietary Polyphenols Prevent the Formation of Toxic Compounds from Maillard Reaction? 29
Disfunzione endoteliale: verso una visione integrata degli aspetti fisiopatologici e diagnostici 29
Effects of cerium oxide nanoparticles on hemostasis: Coagulation, platelets, and vascular endothelial cells 29
Advanced glycosylation end-products and the pathogenesis of accelerated atherosclerosis in diabetes | I prodotti di glicosilazione ayanzata e la patogenesi dell'aterosclerosi accelerata nel diabete 29
n-3 fatty acids and the inflammatory response - biological background 29
Soluble receptor of advanced glycation end-product levels are elevated in patients with acute coronary syndrome and positive troponin I 28
A paradoxical increase in the surface expression of various cell adhesion molecules in human endothelial cells after treatment with statins 28
In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound 28
Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk 28
Meccanismi molecolari di azione dei fattori di rischio cardiovascolare. 28
null 28
Influence of insulin resistance, pro- and anti-inflammatory markers, on soluble receptor for advanced glycation end-products (sRAGE) 27
Increased FNDC5/Irisin expression in human hepatocellular carcinoma 27
Development and validation of a risk stratification score for new-onset atrial fibrillation in STEMI patients undergoing primary percutaneous coronary intervention 27
Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis 27
Specific effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts 26
Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis 26
Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts 26
Placca aterosclerotica vulnerabile: le caratteristiche istologiche, cellulari e molecolari 26
Endothelial cell transfections: a way for studying promoter activity of genes involved in atherogenesis 26
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease 26
Plasma levels of soluble RAGE increase six months after percutaneous coronary interventions with stenting in coronary artery disease patients 25
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men 25
Low levlels of circulating soluble receptor for advanced glycation end-products in patients with degenerative aortic valve stenosis and cardiovascular calcifications 25
Fisiopatologia di base. Genetica 25
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein 25
Effects of simvastatin on blood levels of lipoprotein (a) 24
At least two distinct pathways generating reactive oxygen species mediate endothelial VCAM-1 induction by advanced glycation endproducts 24
Totale 4.147
Categoria #
all - tutte 19.546
article - articoli 15.084
book - libri 91
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 649
Totale 35.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202436 0 0 0 0 0 0 0 0 11 5 19 1
2024/20252.099 23 16 165 104 360 75 43 102 56 89 597 469
2025/20263.562 183 300 287 549 698 168 669 193 235 197 83 0
Totale 5.697